| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.01 |